We believe that no other biomedical discipline has greater implications for human health than immunology. By unraveling the complexities of the immune system, LJI researchers are directly tackling an extraordinarily diverse array of diseases, such as asthma, cancer, CoVID-19, type 1 diabetes, Parkinson’s, and many others.
At La Jolla Institute for Immunology, every day, our discoveries move the world closer to Life Without Disease.
La Jolla Institute is home to three research centers that focus the efforts of collaborative groups of researchers on defined areas of inquiry, to accelerate progress toward the development of new treatments and vaccines to prevent and cure autoimmune conditions, cancer and infectious disease.
Research into different autoimmune diseases can inform the development of new treatments that teach the immune system to tolerate the body’s own cells.
The Center is at the forefront of exploring new and sometimes unexpected avenues for novel immune-based cancer treatments.
Amid the COVID-19 pandemic, LJI infectious disease experts quickly mobilized a task force to respond to the current crisis.
New study highlights VP40 as a promising therapeutic target
Reactions reflect unique features of an individual’s immune system, not the strength of a response
Antibodies can change to counter new forms of the shape-shifting virus, research hints
Speaker: Ikuo Takazawa, Ph.D.
La Jolla Institute for Immunology
Host: Hilde Cheroutre
Link: Webinar Link
Speaker: Ricardo DaSilva, Ph.D.
La Jolla Institute for Immunology
Host: Alessandro Sette, Dr Biol. Sci
Link: Webinar Link